Another study showed that silencing SIRT6 induced ferroptosis in gastric cancer cells by inducing inactivation of Keap1-Nrf2 and low expression of GPX4, thereby improving the sensitivity of gastric cancer cells to sorafenib [87]. The gene discussed is GPX4; the disease is gastric cancer.